Niagen Bioscience, Inc. (NAGE) — Cash Flow Reinvestment Rate
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $48.00K (capex $24.00K plus investments $-24.00K) from operating cash flow of $3.69 Million. Check Niagen Bioscience, Inc. (NAGE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Niagen Bioscience, Inc. Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Niagen Bioscience, Inc. across 2 annual periods. Explore how well can Niagen Bioscience, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Niagen Bioscience, Inc. (2023–2024)
Year-by-year capital reinvestment analysis for Niagen Bioscience, Inc.. For live market cap and broader valuation context, see Niagen Bioscience, Inc. (NAGE) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $306.00K | $12.11 Million | $163.00K | ▼ -38.2% |
| 2023 | 0.04x | $291.00K | $7.12 Million | $148.00K | — |